Terms ending in 2030
Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,464,269 | Method of Enhancing Cell Growth Using Alkyl-Amine-N-Oxide (AANOX) In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,143,347 | Pegylation of Recombinant Blood Coagulation Factors in the Presence of Bound Antibodies In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,388,847 | Methods of Concentrating Shear-Sensitive Biopolymers In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,445,544 | Hydrolysable Polymeric FMOC-Linker In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,637,007 | Factor Viia-Polysialic Acid Conjugate Having Prolonged in Vivo Half-Life In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,173,597 | Modified Recombinant Factor VIII and Von Willebrand Factor and Methods of Use In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,288,101 | Method for the Specific Detection of Low Abundance RNA Species in a Biological Sample In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,216,793 | Detection of Antibody That Binds to Water Soluble Polymer-Modified Polypeptides In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,889,838 | Removal of Serine Proteases by Treatment with Finely Divided Silicon Dioxide In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,921,520 | Removal of Serine Proteases by Treatment with Finely Divided Silicon Dioxide In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| 49 more term ends in 2030 · Pro | |||||
10 of 59 patents shown. Soonest term end first, then patent number.
Pro members see all 59.
4 of these are in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.